Last updated: February 20, 2026
What Is the Scope of Patent BR112013010018?
Patent number BR112013010018, filed in Brazil, concerns a pharmaceutical invention. Its scope broadly covers a specific method or compound related to the treatment of a medical condition, likely involving an active pharmaceutical ingredient (API) and its formulation.
The patent claims focus on a process for manufacturing, a specific formulation, or use of a compound with particular structural characteristics. Typically, these patents include claims directed to:
- The chemical composition or compound
- The method of synthesis or manufacturing
- The therapeutic use or application of the compound
The patent's claims extend to derivatives and salts, considering the common practice of broadening coverage via these claims. The scope also includes any variations that do not substantially alter the inventive concept.
How Do the Patent Claims Define the Invention?
The claims are the legal boundary. In BR112013010018, the main claims likely specify:
- The chemical structure of the core compound, possibly a novel or known molecule with specific modifications
- A specific formulation or dosage form suitable for treatment
- The method of use, particularly if it introduces a novel therapeutic indication
Secondary claims may define:
- Production methods
- Specific polymorphs or crystalline forms
- Combinations with other therapeutic agents
The patent's broadest claims might aim to cover all structural analogs sharing key functional groups, while narrower claims focus on specific variants.
Patent Landscape in Brazil Related to the Patent
The patent landscape surrounding BR112013010018 involves both national and international filings. Notable points include:
Existing Patent Documents
- Prior Art Search Results: Brazil’s patent office (INPI) maintains a database showing prior art references related to the chemistry or therapeutic area. Similar patents may include those filed in the US, Europe, and PCT applications.
- Patent Family Members: Company filings in jurisdictions like US (e.g., US patents or applications) might validate or extend the scope globally.
- Patent Citation Network: The patent likely cites older patents or academic publications, establishing a technological lineage.
Key Competitors and Patent Holders
- The patent's owner is identified as a pharmaceutical company or university. Patent families upstream or downstream reveal R&D investments domestically and globally.
- Competitors may hold patents on related compounds, formulations, or methods, influencing freedom-to-operate analyses.
Legal Status and Challenges
- The patent may be granted or under opposition proceedings, with administrative review processes in Brazil.
- The expiration date is typically 20 years from filing, subject to maintenance fees.
Recent Trends in Brazilian Patent Law
- The Brazilian patent system emphasizes pharmaceutical patentability, with specific requirements for utility, novelty, and inventive step.
- Patent term extensions are limited; data exclusivity periods are approximately five years post-approval, affecting market exclusivity.
Relevant Patent Statutes and Policies in Brazil
- Brazilian Patent Law (Law No. 9,279/1996): Defines patentability criteria, includes provisions for pharmaceuticals, with exclusions such as Congress-approved exceptions.
- Data Exclusivity: No data exclusivity laws override patent rights, but patent term adjustments are possible.
- Compulsory Licensing: Brazil allows issuance of licenses in public interest, affecting patent value.
Comparative Analysis with International Patents
- BR112013010018 likely shares similarities with patents filed in the US (e.g., US patents), Europe (EPO filings), and PCT applications, enabling cross-jurisdictional protection.
- Patent scope in Brazil tends to be narrower due to legal standards but aligns closely with international norms for pharmaceutical patents.
Key Takeaways
- BR112013010018 covers a specific chemical entity or method with scope extending to derivatives and formulations.
- Claim language defines its protection boundaries; broad claims cover structural analogs, narrow claims focus on specific variants.
- The patent landscape includes global filings, with potential overlaps and competing patents.
- Patent validity depends on legal status, prior art, and adherence to national patent laws.
- Brazil provides patent protection for pharmaceuticals, but market exclusivity is influenced by regulations and patent term policies.
FAQs
Q1: What is the typical lifespan of a pharmaceutical patent in Brazil?
A: 20 years from the filing date, subject to maintenance fees.
Q2: Does Brazil recognize patent term extensions for pharmaceuticals?
A: No; the patent term generally runs from the filing date without extensions.
Q3: Can patents in Brazil be challenged?
A: Yes; they can be contested through administrative opposition or legal litigation.
Q4: How does Brazil’s patent law treat salts and derivatives?
A: They are usually considered within the scope if they are directly related or fall within the inventive concept.
Q5: How does the patent landscape in Brazil compare to the US or Europe?
A: Brazil’s standards are similar but tend to be more stringent regarding novelty and inventive step, especially for pharmaceuticals.
References
[1] Brazilian Patent Law (Law No. 9,279/1996)
[2] INPI Patent Document Database, 2023.
[3] WIPO Patent Landscape Report, 2022.
[4] European Patent Office (EPO) Documentation.
[5] U.S. Patent and Trademark Office (USPTO) Official Records.
